Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
Kura Oncology, Inc.
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Stanford University
University of Washington
Beijing 302 Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
Institute of Hematology & Blood Diseases Hospital, China
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Washington University School of Medicine
Astellas Pharma Inc
St. Jude Children's Research Hospital
City of Hope Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Astellas Pharma Inc
Washington University School of Medicine
M.D. Anderson Cancer Center
Astellas Pharma Inc
Hospital General de Mexico
Children's Hospital Medical Center, Cincinnati
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center